Skip to main content
Log in

5-Azacytidine (NSC 102816) in refractory germ cell tumors

A phase II trial of the Eastern Cooperative Oncology Group

  • Brief Report
  • Phase II Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Friedman S: The inhibition of DNA (cytosine-5) methylases by 5-azacytidine. The effect of azacytosine-containing DNA. Mol Pharmacol 19:314–320, 1981

    Google Scholar 

  2. Riggs AD, Jones PA: 5-methlycytosine, gene regulation, and cancer. Adv Canc Res 40:1–29, 1985

    Google Scholar 

  3. Jones PA, Taylor SM: Cellular differentiation, cytidine analogs, and DNA methylation. Cell 20:85–93, 1980

    Google Scholar 

  4. Razin A, Webb C, Szyf M, Yisraeli J, Rosenthal A, NavehMany T, Sciaky-Gallili N, Cedar H: Variations in DNA methylation during mouse cell differentiationin vivo andin vitro. Proc Natl Acad Sci (USA) 81:2275–2279, 1984

    Google Scholar 

  5. Darmon M, Nicolas JF, Lamblin D: 5-azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelial cells. EMBO J 3:961–967, 1984

    Google Scholar 

  6. Quagliana JM, O'Bryan RM, Baker L, Gottlieb J, Morrison FS, Eyre JH, Tucker WG, Costanzi J: Phase II study of 5-azacytidine in solid tumors. Canc Treat Rep 61:51–54, 1977

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Other participating institutions include: Mayo Clinic, Rochester, MN (CA 13650); University of Pennsylvania Cancer Center, Philadelphia, PA (CA 15488); University of Wisconsin Comprehensive Cancer Center, Madison, WI (CA 21076), USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roth, B.J., Elson, P., Sledge, G.W. et al. 5-Azacytidine (NSC 102816) in refractory germ cell tumors. Invest New Drugs 11, 201–202 (1993). https://doi.org/10.1007/BF00874155

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00874155

Key words

Navigation